【Lotus Pharmaceutical】Announcement of board resolution to approve capital increase in Singaporean subsidiary Lotus International Pte. Ltd.
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Lotus Pharmaceutical's board of directors approved a capital increase in its Singaporean subsidiary, Lotus International Pte. Ltd. This will be carried out by contributing the ownership of its Japanese subsidiary, Lotus Japan Holdings Co., Ltd., in kind, aiming to adjust the group's investment structure.